연구성과로 돌아가기

2020 연구성과별 연구자 정보 (1509 / 2428)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Pharmacodynamics of Ceftiofur Selected by Genomic and Proteomic Approaches of Streptococcus parauberis Isolated from the Flounder, Paralichthys olivaceus Abbas, Muhammad Aleem Abbas, MA 2 Kyungpook Natl Univ, Coll Vet Med, Lab Vet Pharmacokinet & Pharmacodynam, Daegu 41569, South Korea GLT-8362-2022 Abbas, Muhammad Aleem 0000-0002-1071-4176 Abbas Shah, Syed Muhammad Aleem nailaboby1584@gmail.com;syedaleemabbas77@gmail.com;eonbee@gmail.com;parksch@knu.ac.kr;
Pharmacodynamics of Ceftiofur Selected by Genomic and Proteomic Approaches of Streptococcus parauberis Isolated from the Flounder, Paralichthys olivaceus Lee, Eon-Bee Lee, EB 3 Kyungpook Natl Univ, Coll Vet Med, Lab Vet Pharmacokinet & Pharmacodynam, Daegu 41569, South Korea HHZ-3200-2022 Lee, Jung Bok nailaboby1584@gmail.com;syedaleemabbas77@gmail.com;eonbee@gmail.com;parksch@knu.ac.kr;
Pharmacodynamics of Ceftiofur Selected by Genomic and Proteomic Approaches of Streptococcus parauberis Isolated from the Flounder, Paralichthys olivaceus Park, Seung-Chun Park, SC 4 교신저자 Kyungpook Natl Univ, Coll Vet Med, Lab Vet Pharmacokinet & Pharmacodynam, Daegu 41569, South Korea AAV-3388-2021 Park, Seung-Chun nailaboby1584@gmail.com;syedaleemabbas77@gmail.com;eonbee@gmail.com;parksch@knu.ac.kr;
Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome againstStreptococcus equisubsp.equiin foals Lee, Dong-Ha Lee, DH 1 Kyungpook Natl Univ, Coll Vet Med, Lab Vet Pharmacokinet & Pharmacodynam, Bukgu 41566, Daegu, South Korea 0000-0002-8898-3632 Lee, Dong-Ha parksch@knu.ac.kr;
Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome againstStreptococcus equisubsp.equiin foals Birhanu, Biruk Tesfaye Birhanu, BT 2 Kyungpook Natl Univ, Coll Vet Med, Lab Vet Pharmacokinet & Pharmacodynam, Bukgu 41566, Daegu, South Korea F-1622-2017 Birhanu, Biruk 0000-0002-5261-8406 Birhanu, Biruk parksch@knu.ac.kr;
Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome againstStreptococcus equisubsp.equiin foals Lee, Eon-Bee Lee, EB 3 Kyungpook Natl Univ, Coll Vet Med, Lab Vet Pharmacokinet & Pharmacodynam, Bukgu 41566, Daegu, South Korea parksch@knu.ac.kr;
Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome againstStreptococcus equisubsp.equiin foals Lee, Seung-Jin Lee, SJ 4 Korean Inst Toxicol, Dev & Reprod Toxicol Res Grp, Daejeon 34114, South Korea CAI-2335-2022 Lee, Jun Young parksch@knu.ac.kr;
Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome againstStreptococcus equisubsp.equiin foals Boby, Naila Boby, N 5 Kyungpook Natl Univ, Coll Vet Med, Lab Vet Pharmacokinet & Pharmacodynam, Bukgu 41566, Daegu, South Korea GRE-8096-2022 Boby, Naila 0000-0002-7764-6067 Boby, Naila parksch@knu.ac.kr;
Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome againstStreptococcus equisubsp.equiin foals Park, Yong-Soo Park, YS 6 교신저자 Korea Natl Coll Agr & Fisheries, Dept Equine Ind, Jeonju 54874, South Korea AAR-8033-2021 Park, Yong-Soo parksch@knu.ac.kr;
Pharmacokinetic and pharmacodynamic integration for optimal dosage of cefquinome againstStreptococcus equisubsp.equiin foals Park, Seung-Chun Park, SC 7 교신저자 Kyungpook Natl Univ, Coll Vet Med, Lab Vet Pharmacokinet & Pharmacodynam, Bukgu 41566, Daegu, South Korea AAV-3388-2021 Park, Seung-Chun parksch@knu.ac.kr;
Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects Lee, Hae Won Lee, HW 1 Kyungpook Natl Univ, Sch Med, Daegu 41566, South Korea yry@knu.ac.kr;wintersj@knu.ac.kr;
Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects Lee, Hae Won Lee, HW 1 Kyungpook Natl Univ Hosp, Dept Clin Pharmacol, Daegu 41566, South Korea yry@knu.ac.kr;wintersj@knu.ac.kr;
Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects Kang, Woo Youl Kang, WY 2 Kyungpook Natl Univ, Sch Med, Daegu 41566, South Korea yry@knu.ac.kr;wintersj@knu.ac.kr;
Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects Kang, Woo Youl Kang, WY 2 Kyungpook Natl Univ Hosp, Dept Clin Pharmacol, Daegu 41566, South Korea yry@knu.ac.kr;wintersj@knu.ac.kr;
Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects Jung, Wookjae Jung, W 3 Kyungpook Natl Univ, Sch Med, Daegu 41566, South Korea 0000-0002-9607-9731 Jung, Wookjae yry@knu.ac.kr;wintersj@knu.ac.kr;
페이지 이동: